Related references
Note: Only part of the references are listed.Imaging patterns of gray and white matter abnormalities associated with PASAT and SDMT performance in relapsing-remitting multiple sclerosis
Gianna C. Riccitelli et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Effects of an individual 12-week community-located start-to-run program on physical capacity, walking, fatigue, cognitive function, brain volumes, and structures in persons with multiple sclerosis
Peter Feys et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Imaging patterns of gray and white matter abnormalities associated with PASAT and SDMT performance in relapsing-remitting multiple sclerosis
Gianna C. Riccitelli et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Effects of an individual 12-week community-located start-to-run program on physical capacity, walking, fatigue, cognitive function, brain volumes, and structures in persons with multiple sclerosis
Peter Feys et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
The link between depression and performance on the Symbol Digit Modalities Test: Mechanisms and clinical significance
Viral P. Patel et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
The link between depression and performance on the Symbol Digit Modalities Test: Mechanisms and clinical significance
Viral P. Patel et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Preserved network functional connectivity underlies cognitive reserve in multiple sclerosis
Tom A. Fuchs et al.
HUMAN BRAIN MAPPING (2019)
Evaluation of multiple sclerosis disability outcome measures using pooled clinical trial data
Myla D. Goldman et al.
NEUROLOGY (2019)
Symbol Digit Modalities Test: A valid clinical trial endpoint for measuring cognition in multiple sclerosis
Lauren Strober et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Brain functional and effective connectivity underlying the information processing speed assessed by the Symbol Digit Modalities Test
P. H. R. Silva et al.
NEUROIMAGE (2019)
The next-generation sphingosine-1 receptor modulator BAF312 (siponimod) improves cortical network functionality in focal autoimmune encephalomyelitis
Petra Hundehege et al.
NEURAL REGENERATION RESEARCH (2019)
The Xenopus tadpole: An in vivo model to screen drugs favoring remyelination
Abdelkrim Mannioui et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Improved cognitive outcomes in patients with relapsing-remitting multiple sclerosis treated with daclizumab beta: Results from the DECIDE study
Ralph H. B. Benedict et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability
Nicholas G. LaRocca et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
The Xenopus tadpole: An in vivo model to screen drugs favoring remyelination
Abdelkrim Mannioui et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Improved cognitive outcomes in patients with relapsing-remitting multiple sclerosis treated with daclizumab beta: Results from the DECIDE study
Ralph H. B. Benedict et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability
Nicholas G. LaRocca et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
Ludwig Kappos et al.
LANCET (2018)
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
Raja Kapoor et al.
LANCET NEUROLOGY (2018)
Cognition in multiple sclerosis: State of the field and priorities for the future
James F. Sumowski et al.
NEUROLOGY (2018)
Information processing speed in multiple sclerosis: Past, present, and future
Silvana L. Costa et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Information processing speed in multiple sclerosis: Past, present, and future
Silvana L. Costa et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Neuropsychology of Multiple Sclerosis: Looking Back and Moving Forward
Ralph H. B. Benedict et al.
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2017)
Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis
Ralph H. B. Benedict et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Distinct cognitive impairments in different disease courses of multiple sclerosis-A systematic review and meta-analysis
Andreas Johnen et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2017)
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
S. L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis
Ralph H. B. Benedict et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) and performance of everyday life tasks: Actual Reality
Yael Goverover et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Relationship between brain volume loss and cognitive outcomes among patients with multiple sclerosis: a systematic literature review
Timothy Vollmer et al.
NEUROLOGICAL SCIENCES (2016)
Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) and performance of everyday life tasks: Actual Reality
Yael Goverover et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis
Antonietta Gentile et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Localized atrophy of the thalamus and slowed cognitive processing speed in MS patients
Niels Bergsland et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Localized atrophy of the thalamus and slowed cognitive processing speed in MS patients
Niels Bergsland et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Connectivity-based parcellation of the thalamus in multiple sclerosis and its implications for cognitive impairment: A multicenter study
Alvino Bisecco et al.
HUMAN BRAIN MAPPING (2015)
Isolated cognitive relapses in multiple sclerosis
Matteo Pardini et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Reliability of a cognitive endpoint for use in a multiple sclerosis pharmaceutical trial
David M. Erlanger et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2014)
Comparing long-term results of PASAT and SDMT scores in relation to neuropsychological testing in multiple sclerosis
Judith M. Sonder et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Characterizing cognitive function during relapse in multiple sclerosis
Ralph H. B. Benedict et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
The relationship between executive functioning, processing speed, and white matter integrity in multiple sclerosis
Helen M. Genova et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2013)
The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate
P. Gergely et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MS
Bianca Weinstock-Guttman et al.
JOURNAL OF NEUROLOGY (2012)
Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects
Jeffrey A. Cohen et al.
LANCET NEUROLOGY (2012)
Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)
D. W. Langdon et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Revisiting The Multiple Sclerosis Functional Composite: proceedings from the National Multiple Sclerosis Society (NMSS) Task Force on Clinical Disability Measures
D. Ontaneda et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Reliability and equivalence of alternate forms for the Symbol Digit Modalities Test: implications for multiple sclerosis clinical trials
Ralph H. B. Benedict et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Cognition in multiple sclerosis
Dawn W. Langdon
CURRENT OPINION IN NEUROLOGY (2011)
Fingolimod modulates microglial activation to augment markers of remyelination
Samuel J. Jackson et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Effects of acute relapses on neuropsychological status in multiple sclerosis patients
S. A. Morrow et al.
JOURNAL OF NEUROLOGY (2011)
Predicting loss of employment over three years in multiple sclerosis: clinically meaningful cognitive decline
Sarah A. Morrow et al.
CLINICAL NEUROPSYCHOLOGIST (2010)
Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test
A. S. Drake et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Cognitive reserve moderates the negative effect of brain atrophy on cognitive efficiency in multiple sclerosis
James F. Sumowski et al.
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2009)
Information-processing speed is the primary deficit underlying the poor performance of multiple sclerosis patients in the Paced Auditory Serial Addition Test (PASAT)
C. Forn et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2008)
Thalamic atrophy and cognition in multiple sclerosis
M. K. Houtchens et al.
NEUROLOGY (2007)
Secondary progressive multiple sclerosis: current knowledge and future challenges
M Rovaris et al.
LANCET NEUROLOGY (2006)
A comprehensive review of the Paced Auditory Serial Addition Test (PASAT)
TN Tombaugh
ARCHIVES OF CLINICAL NEUROPSYCHOLOGY (2006)
Within session practice effects on the PASAT in clients with multiple sclerosis
SL Barker-Collo
ARCHIVES OF CLINICAL NEUROPSYCHOLOGY (2005)
Is speed of processing or working memory the primary information processing deficit in multiple sclerosis?
J DeLuca et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2004)
Minimal neuropsychological assessment of MS patients: A consensus approach
RHB Benedict et al.
CLINICAL NEUROPSYCHOLOGIST (2002)
Share Paper
